Christina Addison

Ontario Institute for Cancer Research — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

39h-index6.9kcitations164works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(33), Bone health and treatments(31), Viral Infectious Diseases and Gene Expression in Insects(25), Cancer Research and Treatments(21), Cell Adhesion Molecules Research(17)

Publications164 total

Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer
Current Oncology·2026Open Access
Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype
Journal of bone oncology·2026Open Access
Leveraging Pharmacy Education through a Train-the-Trainer Model to Enhance Breast Cancer Literacy in Rural Communities
Journal of Cancer Education·2025Open Access
Leveraging Pharmacy Education through a Train-the-Trainer Model to Enhance Breast Cancer Literacy in Rural Communities
2025Open Access
It’s a Trap! Aldolase-Prescribed C<sub>4</sub>Deoxyradiofluorination Affords Intracellular Trapping and the Tracing of Fructose Metabolism by PET
Journal of Nuclear Medicine·2024· 3 citedOpen Access
Supplementary Methods from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 3 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figures S1-S7 from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
2023Open Access
Supplementary Figure 2 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Data from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Table S1 from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
2023Open Access
Supplementary Figure 2 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure Legends from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
2023Open Access
Supplementary Table 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 4 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure Legends from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
2023Open Access
Supplementary Video 2 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Table S1 from Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
2023Open Access
Data from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 3 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Robert M. Strieter(9), Jim Dimitroulakos(7), Douglas A. Arenberg(6), Marie D. Burdick(6), Frank L. Graham(6), Mark Clemons(6), Mary Hitt(5), Jack Gauldie(5), Angel Arnaout(5), Michael P. Keane(4), John C. Bell(4), Bethany B. Moore(4), Felicia L. Graham(4), Iryna Kuchuk(4), Brian Hutton(4), Grant A. Howe(4), Lisheng Wang(4), John Marshall(4), Huijun Zhao(4), Peter J. Polverini(3)